ASC-话题@MedSci

#ASC#

1352篇内容 | 3934人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939495, encodeId=2e59193949507, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良, objectType=article, longId=739206, objectId=df2ee39206bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2ee39206bd, replyNumber=0, likeNumber=82, createdTime=2023-03-19, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2ee39206bd, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2ee39206bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939485, encodeId=38e4193948539, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：项目基线健康研究中糖尿病前期的多维表征, objectType=article, longId=736347, objectId=9be9e363471c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9be9e363471c, replyNumber=0, likeNumber=46, createdTime=2023-04-18, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9be9e363471c, moduleTitle=Cardiovasc Diabetol：项目基线健康研究中糖尿病前期的多维表征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9be9e363471c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939338, encodeId=3f3219393385c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：长期服用二甲双胍对糖尿病患者心肌肌钙蛋白水平的影响, objectType=article, longId=723867, objectId=4ea6e23867d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ea6e23867d6, replyNumber=0, likeNumber=70, createdTime=2022-09-27, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ea6e23867d6, moduleTitle=Cardiovasc Diabetol：长期服用二甲双胍对糖尿病患者心肌肌钙蛋白水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ea6e23867d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939339, encodeId=733f193933947, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：DPP-4抑制剂、GLP-1受体激动剂和SGLT-2抑制剂对心肾结局的影响, objectType=article, longId=723796, objectId=c62be2379617, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c62be2379617, replyNumber=0, likeNumber=72, createdTime=2022-06-11, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c62be2379617, moduleTitle=Cardiovasc Diabetol：DPP-4抑制剂、GLP-1受体激动剂和SGLT-2抑制剂对心肾结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c62be2379617)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939448, encodeId=70cb1939448b6, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：150万人血浆甘油三酯浓度升高与不良临床结果的风险, objectType=article, longId=729721, objectId=a86ce29721f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a86ce29721f0, replyNumber=0, likeNumber=90, createdTime=2022-10-21, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a86ce29721f0, moduleTitle=Cardiovasc Diabetol：150万人血浆甘油三酯浓度升高与不良临床结果的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a86ce29721f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939434, encodeId=244d1939434f2, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | PALOMA-2研究最终数据出炉：全球首款CDK4/6抑制剂哌柏西利再受挫！ , objectType=article, longId=729095, objectId=d5c5e2909563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5c5e2909563, replyNumber=0, likeNumber=72, createdTime=2022-07-29, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5c5e2909563, moduleTitle=ASCO 2022 | PALOMA-2研究最终数据出炉：全球首款CDK4/6抑制剂哌柏西利再受挫！ , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5c5e2909563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939470, encodeId=8c8719394e084, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：合并糖尿病对ICD植入患者死亡率及治疗的影响, objectType=article, longId=734342, objectId=17ade34342e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ade34342e3, replyNumber=0, likeNumber=99, createdTime=2022-09-28, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ade34342e3, moduleTitle=Cardiovasc Diabetol：合并糖尿病对ICD植入患者死亡率及治疗的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17ade34342e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939476, encodeId=4ab719394e6c0, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：使用SGLT2i、GLP1RA和DPP-4抑制剂治疗的2型糖尿病患者发生房颤的风险, objectType=article, longId=735642, objectId=ed39e3564211, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed39e3564211, replyNumber=0, likeNumber=143, createdTime=2022-09-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed39e3564211, moduleTitle=Cardiovasc Diabetol：使用SGLT2i、GLP1RA和DPP-4抑制剂治疗的2型糖尿病患者发生房颤的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed39e3564211)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939398, encodeId=af041939398ec, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：诱导方法对新诊断急性髓系白血病（AML）老年人干细胞移植后（SCT）结局的影响, objectType=article, longId=728482, objectId=11b6e28482e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11b6e28482e3, replyNumber=0, likeNumber=75, createdTime=2023-04-14, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11b6e28482e3, moduleTitle=2022 ASCO：诱导方法对新诊断急性髓系白血病（AML）老年人干细胞移植后（SCT）结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11b6e28482e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939459, encodeId=3c411939459a0, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：甘油三酯-葡萄糖指数和剩余SYNTAX评分在预测接受经皮冠状动脉介入治疗的2型糖尿病患者中期主要心脏不良事件中的协同作用, objectType=article, longId=732999, objectId=5892e3299934, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5892e3299934, replyNumber=0, likeNumber=74, createdTime=2023-07-07, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5892e3299934, moduleTitle=Cardiovasc Diabetol：甘油三酯-葡萄糖指数和剩余SYNTAX评分在预测接受经皮冠状动脉介入治疗的2型糖尿病患者中期主要心脏不良事件中的协同作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5892e3299934)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939352, encodeId=7a111939352f5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：血浆磷酸盐水平越高，糖尿病患者的死亡风险越高！, objectType=article, longId=726282, objectId=f974e262821c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f974e262821c, replyNumber=0, likeNumber=93, createdTime=2022-11-18, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f974e262821c, moduleTitle=Cardiovasc Diabetol：血浆磷酸盐水平越高，糖尿病患者的死亡风险越高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f974e262821c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939443, encodeId=475719394439b, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：血管活性肽ET-1和ADM与糖尿病风险的相关性, objectType=article, longId=729848, objectId=b148e2984879, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b148e2984879, replyNumber=0, likeNumber=78, createdTime=2022-08-29, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b148e2984879, moduleTitle=Cardiovasc Diabetol：血管活性肽ET-1和ADM与糖尿病风险的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b148e2984879)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939342, encodeId=5a7e193934221, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：胆红素可作为心脏代谢健康的指标, objectType=article, longId=724680, objectId=6386e2468094, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6386e2468094, replyNumber=0, likeNumber=87, createdTime=2023-02-09, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6386e2468094, moduleTitle=Cardiovasc Diabetol：胆红素可作为心脏代谢健康的指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6386e2468094)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939421, encodeId=c24c193942102, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：HbA1c水平有助于预测重症监护室患者的死亡风险, objectType=article, longId=728644, objectId=9ad4e2864413, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ad4e2864413, replyNumber=0, likeNumber=110, createdTime=2023-02-26, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ad4e2864413, moduleTitle=Cardiovasc Diabetol：HbA1c水平有助于预测重症监护室患者的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ad4e2864413)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939417, encodeId=2ec3193941eec, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO：两种检查点抑制剂组合治疗皮肤黑色素瘤的疗效——系统回顾结果, objectType=article, longId=728226, objectId=c05ae282264e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c05ae282264e, replyNumber=0, likeNumber=76, createdTime=2023-02-15, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c05ae282264e, moduleTitle=ASCO：两种检查点抑制剂组合治疗皮肤黑色素瘤的疗效——系统回顾结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c05ae282264e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939444, encodeId=45a6193944440, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：多种营养生物标志物与糖尿病患者心衰结局的相关性, objectType=article, longId=729854, objectId=8094e2985465, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8094e2985465, replyNumber=0, likeNumber=75, createdTime=2023-03-18, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8094e2985465, moduleTitle=Cardiovasc Diabetol：多种营养生物标志物与糖尿病患者心衰结局的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8094e2985465)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939497, encodeId=24e9193949e87, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：GLP-1受体激动剂与SGLT-2抑制剂在2型糖尿病的有效性和安全性, objectType=article, longId=739436, objectId=f1a5e39436f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1a5e39436f8, replyNumber=0, likeNumber=74, createdTime=2023-03-30, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1a5e39436f8, moduleTitle=Cardiovasc Diabetol：GLP-1受体激动剂与SGLT-2抑制剂在2型糖尿病的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1a5e39436f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939426, encodeId=33f61939426fd, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022：神经肿瘤重磅研究荟萃, objectType=article, longId=728705, objectId=b0ece2870549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0ece2870549, replyNumber=0, likeNumber=77, createdTime=2023-02-02, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0ece2870549, moduleTitle=ASCO 2022：神经肿瘤重磅研究荟萃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0ece2870549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939384, encodeId=1cb91939384cc, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：内分泌疗法±辅助化疗治疗ER+HER2-老年乳腺癌患者的长期预后, objectType=article, longId=728383, objectId=8dade283838d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dade283838d, replyNumber=0, likeNumber=83, createdTime=2022-09-25, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dade283838d, moduleTitle=2022 ASCO：内分泌疗法±辅助化疗治疗ER+HER2-老年乳腺癌患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8dade283838d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939496, encodeId=4c1e19394962c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者累积甘油三酯-葡萄糖指数与主要心血管不良事件的相关性, objectType=article, longId=739207, objectId=3765e39207f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3765e39207f7, replyNumber=0, likeNumber=89, createdTime=2023-06-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3765e39207f7, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者累积甘油三酯-葡萄糖指数与主要心血管不良事件的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3765e39207f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良

2023-03-19

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：项目基线健康研究中糖尿病前期的多维表征

2023-04-18

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：长期服用二甲双胍对糖尿病患者心肌肌钙蛋白水平的影响

2022-09-27

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：DPP-4抑制剂、GLP-1受体激动剂和SGLT-2抑制剂对心肾结局的影响

2022-06-11

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：150万人血浆甘油三酯浓度升高与不良临床结果的风险

2022-10-21

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | PALOMA-2研究最终数据出炉：全球首款CDK4/6抑制剂哌柏西利再受挫！

2022-07-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：合并糖尿病对ICD植入患者死亡率及治疗的影响

2022-09-28

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：使用SGLT2i、GLP1RA和DPP-4抑制剂治疗的2型糖尿病患者发生房颤的风险

2022-09-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：诱导方法对新诊断急性髓系白血病（AML）老年人干细胞移植后（SCT）结局的影响

2023-04-14

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：甘油三酯-葡萄糖指数和剩余SYNTAX评分在预测接受经皮冠状动脉介入治疗的2型糖尿病患者中期主要心脏不良事件中的协同作用

2023-07-07

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：血浆磷酸盐水平越高，糖尿病患者的死亡风险越高！

2022-11-18

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：血管活性肽ET-1和ADM与糖尿病风险的相关性

2022-08-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：胆红素可作为心脏代谢健康的指标

2023-02-09

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：HbA1c水平有助于预测重症监护室患者的死亡风险

2023-02-26

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO：两种检查点抑制剂组合治疗皮肤黑色素瘤的疗效——系统回顾结果

2023-02-15

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：多种营养生物标志物与糖尿病患者心衰结局的相关性

2023-03-18

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：GLP-1受体激动剂与SGLT-2抑制剂在2型糖尿病的有效性和安全性

2023-03-30

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022：神经肿瘤重磅研究荟萃

2023-02-02

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：内分泌疗法±辅助化疗治疗ER+HER2-老年乳腺癌患者的长期预后

2022-09-25

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：2型糖尿病患者累积甘油三酯-葡萄糖指数与主要心血管不良事件的相关性

2023-06-24

科室
- - 订阅+
  - 更多科室
工具
服务